🇺🇸 FDA
Pipeline program

Atacicept

VT-001-0050

Phase 3 mab active

Quick answer

Atacicept for IgA Nephropathy is a Phase 3 program (mab) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Vera Therapeutics
Indication
IgA Nephropathy
Phase
Phase 3
Modality
mab
Status
active

Clinical trials